Do herpes zoster patients receive antivirals? A Dutch national survey in general practice

Family Practice

Volumn 22, Issue 5, 2005, Pages 523-528

  Opstelten, Wim ^a   van Essen, Gerrit A ^a   Moons, Karel G M ^a   van Wijck, Albert J M ^a   Schellevis, François G ^b   Kalkman, Cornelis J ^a   Verheij, Theo J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

Author keywords

Guidelines; Herpes zoster; Incidence; Primary care; Treatment

Indexed keywords

AMITRIPTYLINE; ANTIVIRUS AGENT; CORTICOSTEROID; LOCAL ANESTHETIC AGENT;

ADULT; AGED; AGING; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DATA BASE; DRUG USE; FEMALE; GENERAL PRACTICE; HEALTH SURVEY; HERPES ZOSTER; HERPES ZOSTER OPHTHALMICUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NETHERLANDS; POSTHERPETIC NEURALGIA; PRACTICE GUIDELINE; PRESCRIPTION;

ADULT; AGED; ANTIVIRAL AGENTS; FAMILY PRACTICE; FEMALE; GUIDELINE ADHERENCE; HERPES ZOSTER; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NETHERLANDS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES;

EID: 25444508328     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmi055     Document Type: Article

References (30)

1. Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch Intern Med 1995; 155: 1605-1609.
2. Hope-Simpson RE, MRCS. The nature of herpes zoster: A long-term study and a new hypothesis. Proc Royal Soc Med 1965; 58: 9-20.
3. Alper BS, Lewis PR. Treatment of postherpetic neuralgia: A systematic review of the literature. J Fam Pract 2002; 5: 121-128.
4. Cobo M, Foulks GN, Liesegang T, Lass J, Sutphin J, Wilhelmus K et al. Observations on the natural history of herpes zoster ophthalmicus. Curr Eye Res 1987; 6: 195-199.
5. Kost RG, Straus SE. Postherpetic neuralgia-pathogenesis, treatment, and prevention. N Engl J Med 1996; 335: 32-42.
6. Guidelines for the management of shingles. report of a working group of the British Society for the Study of Infection (BSSI). J Infect 1995; 30: 193-200.
7. Balfour HHJ. Antiviral Drugs. N Engl J Med 1999; 340: 1255-1268.
8. Cohen JI, Brunell PA, Straus SE, Krause PR. Recent advances in varicella-zoster virus infection. Ann Intern Med 1999; 130: 922-932.
9. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000; 342: 635-645.
10. Gnann JW Jr, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med 2002; 347: 340-346.
11. Johnson RW. Herpes zoster and postherpetic neuralgia. Optimal treatment. Drugs Aging 1997; 10: 80-94.
12. Gross G, Schofer H, Wassilew S, Friese K, Timm A, Guthoff R et al. Herpes zoster guideline (1) of the German Dermatology Society (DDG). J Clin Virol 2003; 26: 277-289.
13. Peyramond D, Chidiac C, Lucht F, Perronne C, Saimot AG, Soussy JC et al. Management of infections due to the varicella-zoster virus. 11th consensus conference on anti-infectious therapy of the French-speaking Society of Infectious Diseases (SPILF). Eur J Dermatol 1998; 8: 397-402.
14. EBM Guidelines. www.ebm-guidelines.com 2004.
15. Bradley SF. Infections. In Jones R (ed.) Oxford Textbook of Primary Medical Care. Oxford: Oxford University Press; 2004, 1245.
16. Dworkin RH. Prevention of postherpetic neuralgia. Lancet 1999; 353: 1636-1637.
17. Opstelten W, Mauritz JW, de Wit NJ, van Wijck AJ, Stalman WA, van Essen GA. Herpes zoster and postherpetic neuralgia: Incidence and risk indicators using a general practice research database. Fam Pract 2002; 19: 471-475.
18. Westert GP, Schellevis FG, Bakker DHd, Groenewegen PP, Bensing JM, Zee Jvd. Monitoring health inequalities through General Practice: The Second Dutch National Survey of General Practice. Eur J Public Health 2005; 15: 59-65.
19. Joshi GP, Viscusi ER, Gan TJ, Minkowitz H, Cippolle M, Schuller R et al. Effective treatment of laparoscopic cholecystectomy pain with intravenous followed by oral COX-2 specific inhibitor. Anesth Analg 2004; 98: 336-342.
20. Database. ENC. www.Europe.eu.int/comm/euronet.
21. MIXOR. http://tigger.uic.edu/~hedeker/mix.html. 2004.
22. Opstelten W, van Wijck AJM, van Essen GA, Buskens E, Bak AAA, Kalkman CJ et al. The PINE study: Rationale and design of a randomised comparison of epidural injection of local anaesthetics and steroids versus care-as-usual to prevent postherpetic neuralgia in the elderly [ISRCTN32866390]. BMC Anesthesiology 2004; 4.
23. Jung BF, Johnson RW, Griffin DRJ, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004; 62: 1545-1551.
24. Alper BS, Lewis PR. Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia? J Fam Pract 2000; 49: 255-264.
25. Tyring S, Barbarash RA, Nahlik JE, Cunningham A, Marley J, Heng M et al. Famciclovir for the treatment of acute herpes zoster: Effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann Intern Med 1995; 123: 89-96.
26. Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995; 39: 1546-1553.
27. Cobo LM, Foulks GN, Liesegang T, Lass J, Sutphin JE, Wilhelmus K et al. Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. Ophthalmology 1986; 93: 763-770.
28. Whitley RJ, Weiss H, Gnann JW Jr, Tyring S, Mertz GJ, Pappas PG et al. Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med 1996; 125: 376-383.
29. Bowsher D. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: A randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage 1997; 13: 327-331.
30. Opstelten W, van Wijck AJ, Stolker RJ. Interventions to prevent postherpetic neuralgia: Cutaneous and percutaneous techniques. Pain 2004; 107: 202-206.